CHEK2 and breast carcinoma: Specifically, germline mutations in BRCA1, BRCA2, TP53, PTEN, CHEK2, ATM, NBN (also denoted by NBS1), RAD50, BRIP1, and PALB2 are known to be associated with a high risk for breast cancer (Walsh and King, 2007).